YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)

Parker Waichman Alonso LLP Headlines by Topic

Natrecor

Feds Join Lawsuit Alleging Natrecor was Illegally Marketed

Feb 20, 2009 | Parker Waichman Alonso LLP
The United States Justice Department (DOJ) just announced that it is joining in two whistleblower lawsuits against drug maker Scios Inc. and Johnson...

Natrecor a Drag on Johnson & Johnson since Reports of Kidney Failure, Deaths

Dec 6, 2007 | Parker Waichman Alonso LLP
Natrecor side effect reports have taken a toll on the finances of Johnson & Johnson.  Natrecor was considered a potential hit in 2001 when...

Off-label drug marketing: Missing the mark

Oct 22, 2006 | Mercury News
The heart-failure drug Natrecor seemed sure to become a blockbuster after Scios of Fremont put it on the market in 2001. Besides its use in...

Scios to Conduct Safety Study of Natrecor

Jun 1, 2006 | AP
Scios Inc. announced on Thursday that it would spend more than $100 million to conduct a safety and effectiveness study of its controversial heart...

Heart failure drug maker relays new deaths

Jan 3, 2006 | AP
The manufacturer of the heart failure drug Natrecor reported two additional deaths in patients involved in a study carried out three years ago but...

A Growing Clamor over J&J's Natrecor

Oct 6, 2005 | Business Week Europe
The furor over Johnson & Johnson (NYSE: JNJ - news) 's (JNJ) controversial heart failure drug Natrecor shows no signs of abating. In a letter in...

How Johnson & Johnson’s Strategy to Turn Natrecor into a Blockbuster Failed

Aug 25, 2005 | www.Newsinferno.com
In the world of pharmaceuticals, a “blockbuster” is the term reserved for a prescription drug which has annual sales in the...

Scios Heart Drug Curbed

Aug 6, 2005 | San Francisco Chronicle
Fremont biotechnology firm Scios Inc. is taking the first of a series of steps to curb prescribing of its heart drug Natrecor for uses not approved...

Cardiologist: Stop Marketing of Heart Drug

Jul 14, 2005 | Boston Globe
The government should halt sales of the congestive heart failure drug Natrecor until a large study proves it significantly benefits fragile patients,...

Nesiritide — Not Verified

Jul 14, 2005 | New England Journal of Medicine
How can a drug that is associated with higher rates of both renal dysfunction and death than placebo and that costs 50 times as much as standard...

Page 1/3 [first] [prev] 1 2 3 [next] [last]

Natrecor
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Please describe any side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Social Security Disability | Contact
Statement of Clients' Rights | Site Map | Drug Injury Search | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome | Florida Personal Injury Law Firm

© 2002-2009 YourLawyer.com®. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News